Episode 52: Treating Pediatric Migraine
Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Christina Szperka, MD, MSCE.
Episode 52 of the NeurologyLive®
The Mind Moments™ podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.
Episode 52, "Treating Pediatric Migraine," features an exclusive interview with Christina Szperka, MD, MSCE, assistant professor of neurology, and director, Pediatric Headache Program, Children's Hospital of Pennsylvania. She offered up her thoughts on the current state of clinical care and awareness of pediatric migraine and shared her insight into the changes the landscape of treatment has undergone.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
AAN Issues Statement on Ethical Considerations for Aducanumab Use in Alzheimer Disease Enrollment Complete for Phase 2 Study of ATH-1017 in Moderate Alzheimer FDA Accepts sNDA, Grants Priority Review to Fenfluramine for Lennox-Gastaut Syndrome
EPISODE BREAKDOWN
1:15 – The landscape of pediatric migraine
3:00 – Challenges in diagnosing pediatric migraine
5:00 – Parental and patient awareness of signs and symptoms
6:25 – Differences between adult and pediatric migraine
11:35 – Impact of new therapies for pediatric patients
15:00 – Neurology News Minute
17:35 – The day-to-day clinical care of pediatric migraine
20:40 – Medication adherence among children and teens with migraine
24:00 – Transitioning patients from pediatric to adult care
27:40 – Challenges in conducting pediatric migraine studies
30:40 – Biggest advances in the past year and amid COVID-19
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Current Challenges and New Opportunities Ahead for Women in NeurologySeptember 15th 2025
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial UpdateSeptember 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
This Week on NeurologyLive® — September 15, 2025September 15th 2025
